Ramipril: Brands, Price & Uses in Bangladesh

Established / FDA-Approved Uses

• Hypertension: Ramipril is indicated for the treatment of high blood pressure, either alone or in combination with other antihypertensive agents, to lower blood pressure and reduce the risk of fatal and non-fatal cardiovascular events.
• Heart Failure Post-Myocardial Infarction: Ramipril is indicated to reduce the risk of death and to slow progression to severe/resistant heart failure in clinically stable patients who have signs of congestive heart failure within a few days after a heart attack (myocardial infarction).
• Reduction of Cardiovascular Risk: Ramipril is indicated in patients aged 55 years or older at high risk of a major cardiovascular event (such as those with a history of coronary artery disease, stroke, peripheral vascular disease, or diabetes with an additional risk factor) to reduce the risk of myocardial infarction, stroke, and death from cardiovascular causes.

Guideline-Supported / Adjunct Uses

• Diabetic and Non-Diabetic Nephropathy: Ramipril is commonly used, as supported by clinical guidelines, to reduce proteinuria and slow progression of kidney disease in patients with diabetic and certain non-diabetic nephropathies, usually as part of a broader treatment plan.
• Left Ventricular Dysfunction / Chronic Heart Failure: Ramipril may be used as adjunct therapy (with diuretics, beta-blockers, etc.) in the long-term management of chronic heart failure with reduced ejection fraction.

A physician determines the appropriate indication and treatment plan for each patient based on individual clinical evaluation.

General Administration

Ramipril may be taken with or without food, at approximately the same time each day. Doses should be individualized based on indication, blood pressure response, and renal function. Do not stop taking Ramipril abruptly without consulting a physician.

Dosage by Indication

Renal Impairment

Dose reduction is required in renal impairment (see Use in Special Populations for details); the starting dose is typically reduced and titration is done cautiously with monitoring of renal function and potassium.

Common

• Persistent dry, non-productive cough
• Dizziness or lightheadedness (especially with the first dose)
• Headache
• Fatigue
• Hypotension
• Hyperkalemia (elevated blood potassium)

Serious (Less Common but Important)

• Angioedema (swelling of face, lips, tongue, throat, or extremities) - a potentially life-threatening reaction requiring immediate discontinuation and emergency care (see Precautions and Warnings).
• Acute kidney injury or worsening renal function, particularly in patients with pre-existing renal impairment or renal artery stenosis.
• Severe hypotension, especially in volume-depleted patients or those on diuretics.
• Rarely, liver dysfunction, blood dyscrasias (e.g., neutropenia), or severe skin reactions.

Patients should seek prompt medical attention for facial/throat swelling, difficulty breathing or swallowing, or signs of infection (fever, sore throat).